ArticleScientific reports2024
Evaluating the combined effect of sugarcane bagasse ash, metakaolin, and polypropylene fibers in sustainable construction.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Development of sustainable green geopolymer concrete incorporating sugarcane bagasse ash.Scientific reports · 2026Article
- Performance analysis of a biomass gasification combined cycle power plant using rice husk and sugarcane bagasse with circular utilization of ash in green concrete.Scientific reports · 2026Article
- Microstructural insights and thermal properties of a sustainable bio-based geopolymer.Scientific reports · 2026Article
- Performance optimization of rigid pavement concrete using metakaolin treated RCA and silica fume with an experimental and machine learning based approach.Scientific reports · 2025Article
- Experimental and machine learning prediction of compressive strength of chemically activated RHA based RAC using SHAP and PDP analysis.Scientific reports · 2025Article
- Mechanical and environmental performance of sugarcane Bagasse Ash from Khyber Pakhtunkhwa in sustainable concrete.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The major challenge for the construction industry is to design and produce sustainable construction materials that are efficient in their performance and can be affordable for construction projects. The objective of this study is to determine the viability of incorporating waste products such as sugarcane bagasse ash (SCBA) to produce concrete with polypropylene (PP) fibers. SCBA is an industry waste that has certain pozzolanic properties, however, it shows limited mechanical properties when used as a cement replacement. To improve the mechanical and durability performance, metakaolin (15%) and PP fiber (0.5%, 1%, and 1.5%) were incorporated in the SCBA blend as a ternary additive. Some of the important characteristics explored include compressive strength, tensile strength, density, water absorption, acid resistance, and sorptivity. The study reveals that the incorporation of 15% metakaolin in the composite enhanced the compressive strength by 7%, 8.2%, and 9.1% for PP fiber additions of 0.5%, 1%, 1.5%, while the acid resistance enhanced by 4%, 6% and 8% relative to the control mix for the same value of pp fiber. Furthermore, cost evaluation confirms that the overall costs of concrete with 15% metakaolin and 5% SCBA were 12.2% less than the control concrete, thus making this option economically feasible. This research proves that the inclusion of SCBA, metakaolin, and PP fibers into the concrete mixture brings a sustainable approach that enhances mechanical properties and durability while assisting sugar manufacturing plants in the proper disposal of wastes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.